Comparison · NCT04071951-2af728ff
Pharmacist Arm vs Usual Care: Rate (%) of 30-day Post-discharge Hospitalization and ED Visits (Including Hospitals at Least Statewide)
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Pharmacist Arm vs Usual Care: Rate (%) of 30-day Post-discharge Hospitalization and ED Visits (Including Hospitals at Least Statewide). Trial comparisons, record NCT04071951-2af728ff. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04071951-2af728ff
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.26 | 0.242 | 0.278 | wilson | |
| Risk in group 2 | 0.264 | 0.246 | 0.282 | wilson | |
| Risk difference, group 1 minus group 2 | -0.00356 | -0.0289 | 0.0218 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.986 | 0.895 | 1.09 | log | |
| Odds ratio, group 1 over group 2 | 0.982 | 0.861 | 1.12 | log | |
| Number needed to treat, for one fewer participant with the outcome on Pharmacist Arm than on Usual Care | 281 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Pharmacist Arm | Pharmacist-Led Medication Reconciliation, Regimen Review, and Adherence and Literacy Assessment and Counseling~Pharmacist-led Hospital Discharge Care Intervention: Pharmacists will address medication reconciliation, medication adherence, and polypharmacy issues as appropriate. Pharmacists will rely most on their prior training, but study investigators will also encourage the use of documentation templates with reminders, Beers list, deprescribing, motivational interviewing, the Medication Adherence and Literacy tool, and post-discharge phone calls.~Pharmacists will assess patient needs and customize accordingly. All patients will receive one discharge counseling visit and one post-discharge phone call, but pharmacists will find that some patients need further phone calls, interventions, referrals, or other interactions. Some or all of the pharmacist activities may take place over the phone. | 595 | 2,288 | OG000 |
| Group 2 | Usual Care | Patients in this study will receive usual care. Clinically-indicated services, including pharmacist services, may be provided to control group patients. | 610 | 2,314 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Rate (%) of 30-day Post-discharge Hospitalization and ED Visits (Including Hospitals at Least Statewide)
- Description
A patient is readmitted to a hospital (including observation) or has an ED visit within 30 days of discharge (including all hospitals at least statewide), excluding foreseen readmissions, which include: transplants, chemotherapy or radiotherapy, treatment follow-up, rehabilitation care, and planned operations
- Time frame
- Hospitalization to a hospital or ED visit within 30 days of discharge (checking at least all same state facilities)
- Population
- note that to obtain outside hospital data, analysis was restricted to 4602 patients with fee-for-service Medicare (for whom all-hospital claims data was available)
Source ClinicalTrials.gov
Trial
- Title
- Pharmacist Intervention to Reduce Post-Hospitalization Utilization
- NCT number
- NCT04071951
- Phases
- NA
- Conditions
- Nonadherence, Patient, Polypharmacy, Readmission
- Interventions
- Pharmacist-led Hospital Discharge Care Intervention
- Lead sponsor
- Cedars-Sinai Medical Center
- Results first posted
- 2024-10-29
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04071951?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04071951-2af728ff